DrugCite
Search

DECADRON

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Decadron Adverse Events Reported to the FDA Over Time

How are Decadron adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Decadron, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Decadron is flagged as the suspect drug causing the adverse event.

Most Common Decadron Adverse Events Reported to the FDA

What are the most common Decadron adverse events reported to the FDA?

Dyspnoea
289 (.92%)
Drug Ineffective
278 (.88%)
Nausea
278 (.88%)
Hypotension
255 (.81%)
Pneumonia
255 (.81%)
Dizziness
249 (.79%)
Convulsion
235 (.75%)
Fatigue
228 (.73%)
Vomiting
218 (.69%)
Asthenia
213 (.68%)
Pyrexia
202 (.64%)
Show More Show More
Diarrhoea
186 (.59%)
Cardiac Arrest
185 (.59%)
Confusional State
182 (.58%)
Loss Of Consciousness
180 (.57%)
Drug Toxicity
174 (.55%)
Headache
174 (.55%)
Platelet Count Decreased
174 (.55%)
Pain
168 (.53%)
Drug Interaction
160 (.51%)
White Blood Cell Count Decreased
158 (.5%)
Deep Vein Thrombosis
155 (.49%)
Haemoglobin Decreased
155 (.49%)
Pulmonary Embolism
154 (.49%)
Hyperglycaemia
148 (.47%)
Drug Exposure During Pregnancy
147 (.47%)
Anaemia
146 (.46%)
Constipation
143 (.45%)
Oedema Peripheral
140 (.45%)
Overdose
139 (.44%)
Renal Failure Acute
137 (.44%)
Hypertension
136 (.43%)
Sepsis
136 (.43%)
Multiple Myeloma
133 (.42%)
Somnolence
126 (.4%)
Dehydration
121 (.38%)
Blood Glucose Increased
119 (.38%)
Malaise
119 (.38%)
Blood Pressure Decreased
118 (.38%)
Tachycardia
116 (.37%)
Hypoaesthesia
114 (.36%)
Thrombocytopenia
112 (.36%)
Bradycardia
110 (.35%)
Disease Progression
110 (.35%)
Rash
110 (.35%)
Anxiety
109 (.35%)
Death
108 (.34%)
Respiratory Failure
108 (.34%)
Neutropenia
106 (.34%)
Anaphylactic Shock
104 (.33%)
Blood Pressure Increased
104 (.33%)
Medication Error
103 (.33%)
Neutrophil Count Decreased
103 (.33%)
Back Pain
101 (.32%)
Pneumocystis Jiroveci Pneumonia
99 (.31%)
Alanine Aminotransferase Increased
98 (.31%)
Anaphylactic Reaction
97 (.31%)
Agitation
96 (.31%)
Weight Decreased
96 (.31%)
Syncope
95 (.3%)
Muscular Weakness
94 (.3%)
Grand Mal Convulsion
93 (.3%)
Anaesthetic Complication
91 (.29%)
Atrial Fibrillation
91 (.29%)
Neuropathy Peripheral
86 (.27%)
Chest Pain
85 (.27%)
Febrile Neutropenia
85 (.27%)
Erythema
84 (.27%)
Pain In Extremity
84 (.27%)
Fall
83 (.26%)
Insomnia
83 (.26%)
Pleural Effusion
83 (.26%)
Aspartate Aminotransferase Increase...
82 (.26%)
Depressed Level Of Consciousness
82 (.26%)
Coma
81 (.26%)
Infection
81 (.26%)
Methaemoglobinaemia
80 (.25%)
Respiratory Arrest
80 (.25%)
Diabetes Mellitus
79 (.25%)
Oxygen Saturation Decreased
79 (.25%)
Septic Arthritis Staphylococcal
79 (.25%)
Mental Status Changes
77 (.24%)
Condition Aggravated
76 (.24%)
Gait Disturbance
76 (.24%)
Pulmonary Oedema
76 (.24%)
Tremor
75 (.24%)
Heart Rate Increased
74 (.24%)
Herpes Zoster
74 (.24%)
Cardiac Failure Congestive
73 (.23%)
Drug Hypersensitivity
73 (.23%)
Hypokalaemia
73 (.23%)
Palpitations
73 (.23%)
Pancytopenia
73 (.23%)
Hyponatraemia
72 (.23%)
Hypersensitivity
71 (.23%)
Pruritus
71 (.23%)
Malignant Neoplasm Progression
70 (.22%)
Post Procedural Complication
70 (.22%)
Abdominal Pain
69 (.22%)
Hypoxia
69 (.22%)
Shock
69 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Decadron, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Decadron is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Decadron

What are the most common Decadron adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Decadron, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Decadron is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Decadron According to Those Reporting Adverse Events

Why are people taking Decadron, according to those reporting adverse events to the FDA?

Premedication
1879
Multiple Myeloma
1209
Drug Use For Unknown Indication
1057
Prophylaxis
654
Product Used For Unknown Indication
642
Local Anaesthesia
524
Show More Show More
Anaesthesia
468
Pain
277
Prophylaxis Of Nausea And Vomiting
233
Acute Lymphocytic Leukaemia
163
Nausea
135
Prostate Cancer
131
Nerve Block
116
Prostate Cancer Stage Iv
89
Chemotherapy
88
Epidural Anaesthesia
87
Back Pain
84
Brain Oedema
84
Antiemetic Supportive Care
74
Metastases To Central Nervous Syste...
69
Post Herpetic Neuralgia
68
Vomiting
66
Rheumatoid Arthritis
57
Ventricular Tachycardia
52
Inflammation
50
Surgery
50
X-ray
48
Induction Of Anaesthesia
46
Neuralgia
45
Non-hodgkins Lymphoma
44
Cataract Operation
40
Stomatitis
39
Amyloidosis
38
Asthma
37
Arthralgia
37
Ill-defined Disorder
35
X-ray Limb
33
Bronchoscopy
32
Breast Cancer
30
Arrhythmia
29
Pain Management
28
Haemorrhoids
28
Idiopathic Thrombocytopenic Purpura
27
Lymphoma
27
Headache
27
Metastatic Renal Cell Carcinoma
25
Plastic Surgery
24
Analgesic Therapy
24
Analgesia
23
Stem Cell Transplant
22
Oedema
22

Decadron Case Reports

What Decadron safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Decadron. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Decadron.